healthcare

Painting a Clearer Picture of the Heart with Machine Learning

Coronary Artery Disease (CAD) is a condition in which plaque forms on the walls of coronary arteries, causing them to narrow. Eventually, this could lead to a heart attack, or death. This condition is now the single largest health problem in the world, with over one million people in the US undergoing cardiac catheterization – […]

Continue reading

Helping to Improve Medical Image Analysis with Deep Learning

Medical imaging creates tremendous amounts of data: many emergency room radiologists must examine as many as 200 cases each day, and some medical studies contain up to 3,000 images. Each patient’s image collection can contain 250GB of data, ultimately creating collections across organizations that are petabytes in size. Within IBM Research, we see potential in […]

Continue reading

Addressing South Africa’s Cancer Reporting Delay with Machine Learning

Could you make a critical health policy decision using four-year-old data? Cancer registries hold vital data sets, kept tightly encrypted, containing demographic information, medical history, diagnostics and therapy. Oncologists and health officials access the data to understand the diagnosed cancer cases and incidence rates nationally. The ultimate goal is to use this data to inform […]

Continue reading

Using IoT, AI and cloud technologies to advance home-based integrated care

One of the largest growing demographics in the EU is individuals aged 65 and over, and two thirds of this group are in situation of multimorbidity, i.e., perons who suffer from two or more chronic diseases. The ineffective treatment of multimorbidity has been pointed out as an urgent problem to address by the Academy of […]

Continue reading

IBM Names 2018 Fellows, Including Four IBM Researchers

Half of IBM’s 2018 Fellows Hail from IBM Research For more than 70 years, IBM Research has defined the future of technology for IBM. Today, we lead the way forward in AI, blockchain, quantum computing and cybersecurity, thanks to critical foundational research conducted across our global labs. This defining moment in IBM’s transformation is made […]

Continue reading

A new molecule designed to kill deadly, drug-resistant superbugs

In 2016, I had a bacterial infection that I acquired after a routine knee surgery. Fortunately, my immune system reacted favorably to antibiotics, but had the bacteria been a “superbug,” resistant to medication, my story might have had a different ending. This incident inspired me to focus my work on discovering a new solution. With […]

Continue reading

Published in Science: IBM and Memorial Sloan Kettering researchers solve cancer immunotherapy mystery

Cancer immunotherapies, treatment approaches which harness a person’s own immune system to target and kill cancer cells, are currently a major driver in the development of new cancer treatments.  With the advent of next-generation gene editing technologies like CRISPR-Cas9, one could imagine a future in which cancer treatments are tailor-made not only for particular cancer […]

Continue reading

Genomics and AI push the boundary of precision medicine in blood cancer

Every nine minutes, someone in the US dies from blood cancer which accounts for about 10 percent of all cancer deaths. And, every three minutes, one person in the US is diagnosed with a blood cancer — about 170,000 people annually.  In 2017, 62,130 people were expected to be diagnosed with leukemia. [1] These numbers […]

Continue reading

New Research: Unlocking the secrets of Huntington’s Disease

Huntington’s disease (HD) is a devastating neurological disorder that causes death in neurons – a major component of the brain – and eventually the loss of physical and mental abilities. Currently, there are only very limited treatment options. IBM and CHDI Foundation have published research in the Journal of American Chemical Society1 detailing structural features […]

Continue reading

Publishing in The Lancet’s EBioMedicine: New research in AI pushes frontiers in epileptic seizure prediction

Today, The Lancet’s EBioMedicine journal will publish a study led by scientists from IBM Research-Australia and the University of Melbourne marking important progress in personalized seizure forecasting with AI. The findings, described in a paper titled ‘Epileptic Seizure Prediction using Big Data and Deep Learning: Toward a Mobile System,’ present new results in epileptic seizure […]

Continue reading

IBM’s African Scientists Look to Tackle the Continent’s Pressing Healthcare Challenges with AI

A majority of African countries still have fewer than one doctor for every one thousand people, and with the African population expected reach 1.6 billion by 2030, up from 1 billion in 2010, this is not just problematic, but catastrophic. Just as alarming is that the World Health Organization projects that by 2020 the burden […]

Continue reading

Using IoT and machine learning to track the progression of lung disease

Chronic obstructive pulmonary disease, a.k.a. COPD, is a progressive lung disease which causes breathlessness and is often caused by cigarette smoke and air pollution. By 2030, it is expected to be the third leading cause of death worldwide, with 90 percent occurring in low and middle-income countries, according to the World Health Organization. The Centers […]

Continue reading